Formulation Development

Formulation Development
Product Description

We devise and implement product specific development strategies capable of delivering high-quality formulations and robust manufacturing processes.

To achieve our clients’ goal, several studies are performed as a means of achieving deliverables assigned to certain distinct development phases:

  • Preformulation phase: Analysis of bibliographic data, review of existing patents investigation of the most relevant physicochemical properties of the candidate drug substances.
  • Formulation development phase: Screening and optimisation studies, varying in nature depending on project’s particular characteristics, provide the necessary level of information for the provision of the optimum composition. Throughout the development phase, contemporary approaches, aligned with the latest ICH recommendations; including the adoption of Quality by Design (QbD)-oriented principles and tools (e.g. statistical experimental design and risk assessment techniques) are implemented for building up the respective development programmes. Development of analytical methods is integral part of this phase.
  • Process development phase: Screening and optimization process activities, challenging critical process parameters, give rise to robust and transferable processes. The availability of state-of-the-art equipment, fully representative of and simulating that of industrial scale offers large flexibility in the selection of CMOs, facilitating ultimately the smooth transition from R&D to production scale.
  • Scale-up (technology and site transfer activities): Scale-up tasks are effectively undertaken by our skilled team, contributing to the minimizing of tech-transfer risks.
Key areas of expertise
Immediate/modified release dosage forms
  • Tablets
  • Capsules
  • Solutions
  • Suspensions
  • Powders for reconstitution

Topical dosage forms
  • Creams
  • Ointments
  • Cutaneous solutions

Sterile dosage forms
  • Injectables
  • Nasal preparations
  • Ophthalmic preparations

Lamda Laboratories SA

  • GR
  • 2015
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
Primary activities
Pharmaceutical Company (generic finished products)
Specifications

Lamda Laboratories SA

  • GR
  • 2015
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Lamda Laboratories SA (1)

  • GMP Analytical development and validation services

    Product GMP Analytical development and validation services

    Our state-of-the-art laboratories offer a wide range of analytical services to support your exact needs under strict quality procedures which meet GMP requirements and following ICH guidelines.

    The analytical department provides support during the development of drug formulations combini...